DMRA (Damora Therapeutics) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DMRA Damora Therapeutics Inc DMRA
28 GF Score
Price $29.92
! 3 Warning Signs
View Full Analysis

What is Damora Therapeutics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

DMRA vs SLBT, BCAX, TYRA: Short Interest Comparison

For the Biotechnology subindustry, Damora Therapeutics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Damora Therapeutics Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Damora Therapeutics's Short Interest distribution charts can be found below:

* The bar in red indicates where Damora Therapeutics's Short Interest falls into.


DMRA
28GF Score
Damora Therapeutics Inc DMRA
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Damora Therapeutics Business Description

Address 221 Crescent Street, Building 23, Suite 105, Waltham, MA, USA, 02109
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
28GF Score

Get the complete analysis for DMRA

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.92
Price